Skip to main content
. Author manuscript; available in PMC: 2022 Jun 8.
Published in final edited form as: Recent Pat Anticancer Drug Discov. 2021;16(2):122–135. doi: 10.2174/1574892816666210211090845

Table 2.

Patents for CPX and Derivatives as Anticancer Agents.

Patent Number
(Granted Time)		 Title Inventors References
US8609637B2 (Granted 12/17/2013) Prodrugs of 6-cyclohexyl-1-hydroxy-4-4methylyridin-2-(1H)-one and derivatives thereof Mehmet Tanol & Scott J. Weir (University of Kansas) [101]
JP5853028B2 (Granted 02/09/2016) Prodrug of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2 (1H) -one and its derivatives Mehmet Tanol & Scott J. Weir (University of Kansas) [102]
EP2646035B1 (Granted 03/09/2016) Prodrugs of 6-cyclohexyl-1-hydroxy-4-4methylyridin2-(1H)-one and derivatives thereof Mehmet Tanol & Scott J. Weir (University of Kansas) [103]
US9545413B2 (Granted 01/17/2017) Methods of forming ciclopirox or derivatives thereof in a subject by administration of prodrug Mehmet Tanol & Scott Weir (University of Kansas) [104]
US20170304329A1 (Granted 05/11/2017) Methods of bladder cancer treatment with ciclopirox, ciclopirox olamine, or a ciclopirox prodrug Scott J. Weir & Shrikant Anant (University of Kansas) [105]